CD24 and neoplasm: Concerning the expression of CD24 in the four molecular subtypes determined on the basis of immunohistochemical staining for ER, PR, and HER2, CD24 expression varied according to breast cancer subtype (P = 0.041); the HER2 subtype had the highest proportion of CD24-high tumours (39.0%).